Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
((1R,4S,7R,10S,13S,14R,15E,17E,19R,21S)-4-((S)-sec-Butyl)-10-(2-hydroxypropan-2-yl)-19-methoxy-1,3,14,18-tetramethyl-2,5,8,11-tetraoxo-13-phenyl-12,22-dioxa-3,6,9-triazabicyclo[19.1.0]docosa-15,17-dien-7-yl)methyl7-(diethylamino)-2-oxo-2H-chromene-3-carboxylate
ID: ALA5267244
Max Phase: Preclinical
Molecular Formula: C50H66N4O12
Molecular Weight: 915.09
Associated Items:
This compound is not in our inventory system